valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
850.60 | 5.1% | 26.89% | 3,778,836.67 | 1.11% | 18.5% |
|
NYSE:MRK
Merck
|
127.51 | -7.42% | 6.15% | 322,986.42 | 2.42% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
120.50 | 19.51% | 42.34% | 186,803.32 | 2.05% | 15.98% |
|
NYSE:TMO
Thermo Fisher Scientific
|
572.38 | -14.12% | -4.49% | 218,485.38 | 0.27% | 14.15% |
|
SWX:NOVN
Novartis
|
87.97 | 14.79% | 28.99% | 179,494.55 | 3.75% | 4.67% |
|
SWX:ROG
Roche Holding
|
217.30 | 36.77% | 53.45% | 175,193.12 | 4.42% | 0.43% |
|
NYSE:ABT
Abbott Laboratories
|
105.90 | 0.68% | 13.2% | 184,227.29 | 2.08% | 9.04% |
|
NasdaqGS:AMGN
Amgen
|
311.29 | -11.92% | -3.1% | 166,968.34 | 2.89% | 5.31% |
|
NYSE:PFE
Pfizer
|
27.81 | 11.74% | 42.95% | 157,475.27 | 6.04% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
91.30 | 16.54% | 35.07% | 114,001.35 | 4.12% | 8.19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
43.99 | 61.89% | 72.23% | 89,172.13 | 5.46% | 13.54% |
|
LSE:GSK
GSK
|
17.34 | 9.98% | 26.18% | 70,692.55 | 3.35% | 0.79% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
64.78 | 26.38% | 36.06% | 80,778.67 | 4.75% | 0.15% |
|
NYSE:ZTS
Zoetis
|
167.07 | 32.43% | 48.83% | 76,233.23 | 1.03% | 11.19% |
|
TSE:4519
Chugai Pharmaceutical
|
5094.00 | 0% | 0% | 8,381,229.29 | 1.61% | 0% |
|
NasdaqGS:MRNA
Moderna
|
125.00 | -,111.39% | -,107.86% | 47,904.97 | 0% | 0% |
|
NSEI:SUNPHARMA
Sun Pharmaceutical Industries
|
1511.15 | -17.18% | -5.3% | 3,625,755.04 | 0.83% | 24.54% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4125.00 | 0% | 0% | 6,471,852.14 | 4.56% | 0% |
|
XTRA:BAYN
Bayer
|
28.02 | 70.88% | 87.56% | 27,527.52 | 0.39% | 1.47% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
152.33 | 0% | 0% | 19,268.49 | 0% | 0% |
